Journal
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
Volume 79, Issue 2, Pages 392-398Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejpb.2011.05.005
Keywords
Gantrez (R) AN; Polymer hydrolysis; Altered polymer reactivity; Nanoparticles; Oral vaccination; Adjuvant
Categories
Funding
- FWO-Vlaanderen
- IWT-Vlaanderen
Ask authors/readers for more resources
The adjuvant effect of methylvinylether-co-maleic anhydride (Gantrez (R) AN) nanoparticles was investigated during oral vaccination of mice with F4 adhesins of F4-positive Escherichia coli. To differentiate whether the adjuvant effect originated from a nanoparticle effect or a polymer effect, 20 jig F4 was administered as slightly crosslinked F4-containing nanoparticles (g(F4)(0.01)) or as F4 mixed with slightly crosslinked pure nanoparticles (F4 + g(0.01)). The F4-specific immune response was reduced using F4-containing nanoparticles due to complete shielding of F4, whereas oral administration of F4 + g(0.01) increased the level of F4-specific antibody-secreting cells (ASC) in the spleen. When repeating the vaccination study after 6 months using freshly prepared nanoparticles, the adjuvant effect of F4 + g(0.01) was lost due to an altered polymer reactivity caused by partial hydrolysis of anhydride groups of Gantreze (R) AN. Combining F4 with nanoparticles stabilised with a higher crosslinker amount during nanoparticle synthesis (F4 + g(0.22)) could overcome the effect of partial polymer hydrolysis, as higher levels of ASC were detected. Hence, an in-depth characterisation of the GantrezeAN polymer is required as stability issues can alter its biological effect during oral vaccination. (C) 2011 Published by Elsevier B.V.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available